Moreover, in patients with D2T RA, the number of CX3CR1+ T cells persistently increased and PD-1+CD38+CX3CR1+ T cells were identified as a treatment-resistant T cell subset. The gene discussed is CD38; the disease is rheumatoid arthritis.